MOG (35-55), human structure
|
Common Name | MOG (35-55), human | ||
|---|---|---|---|---|
| CAS Number | 163158-19-8 | Molecular Weight | 2591.99000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C120H179N35O28S | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of MOG (35-55), humanMOG (35-55), human is a component of CNS myelin. MOG (35-55), human is different from mMOG (35-55) by a proline for serine substitution at position 42. MOG (35-55), human is also immunogenic, but not encephalitogenic, and is only partially cross-reactive with mMOG35–55. MOG (35-55), human induces minimal clinical signs of EAE relative to the rodent peptide[1]. |
| Name | h-met-glu-val-gly-trp-tyr-arg-pro-pro-phe-ser-arg-val-val-his-leu-tyr-arg-asn-gly-lys-oh |
|---|---|
| Synonym | More Synonyms |
| Description | MOG (35-55), human is a component of CNS myelin. MOG (35-55), human is different from mMOG (35-55) by a proline for serine substitution at position 42. MOG (35-55), human is also immunogenic, but not encephalitogenic, and is only partially cross-reactive with mMOG35–55. MOG (35-55), human induces minimal clinical signs of EAE relative to the rodent peptide[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C120H179N35O28S |
|---|---|
| Molecular Weight | 2591.99000 |
| Exact Mass | 2590.34000 |
| PSA | 1050.31000 |
| LogP | 6.20280 |
| h2n-mevgwyrppfsrvvhlyrngk-oh |
| myelin oligodendrocyte glycoprotein precursor |